Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Royalty Pharma (NASDAQ:RPRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Royalty Pharma (RPRX) operate in?

Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Royalty Pharma Stock (NASDAQ: RPRX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	1.00 / 2.38M
Day Range	- - -
52 Wk Range	25.10 - 31.66
Market Cap	$11.73B
P/E Ratio	10.39
Dividend Yield	3.18%
Exchange	NASDAQ
RSI	45
Short Interest	3.4%
Days to Cover	8.03

Recent News

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields

Avi Kapoor

Rare Disease-Focused Ascendis Pharma Stock Falls On Underwhelming Q2 Earnings, Guidance Cut

Ascendis Pharma reported lower-than-expected Q2 2024 sales of $38.76 million, missing the consensus estimate of $92.7 million due to a significant adjustment to prior sales estimates. The company lowered its full-year sales guidance for Skytrofa. Ascendis also secured a $150 million funding deal with Royalty Pharma based on U.S. sales of Yorvipath.

Vandana Singh

Jim Cramer: This Financial Stock Is A Buy, Core Scientific Is A 'Very Overvalued Situation'

Jim Cramer discusses Snowflake, Royalty Pharma, Core Scientific and Ally Financial on "Mad Money Lightning Round."

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	1.00 / 2.38M
Day Range	- - -
52 Wk Range	25.10 - 31.66
Market Cap	$11.73B
P/E Ratio	10.39
Dividend Yield	3.18%
Exchange	NASDAQ
RSI	45
Short Interest	3.4%
Days to Cover	8.03

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Royalty Pharma (RPRX) stock?

You can purchase shares of Royalty Pharma (NASDAQ:RPRX) through any online brokerage.

View our list of the best stock brokerages

Who are Royalty Pharma (RPRX) competitors?

Other companies in Royalty Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Royalty Pharma (RPRX) stock?

Royalty Pharma has a consensus price target of $45.38.

What is the current price for Royalty Pharma (RPRX)?

The stock price for Royalty Pharma (NASDAQ: RPRX) is $26.4 last updated November 21, 2024 at 4:33 PM EST.

Does Royalty Pharma (RPRX) pay a dividend?

A quarterly cash dividend of 0.21 per share of Class A Common Stock. The quarterly cash dividend was payable on December 10, 2024 to stockholders of record on November 15, 2024.

When is Royalty Pharma (NASDAQ:RPRX) reporting earnings?

Royalty Pharma’s Q4 earnings are confirmed for Thursday, February 13, 2025.

Is Royalty Pharma (RPRX) going to split?

There is no upcoming split for Royalty Pharma.

What sector and industry does Royalty Pharma (RPRX) operate in?

Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Royalty Pharma

Royalty Pharma (RPRX) Forecast